Daily as of 3 Nov 16:00 ET
- Price
- below both $9.59 vs 50 $12.28 / 200 $11.11
- Projection
- ๐Death cross estimated in 14 to 21 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 14 Aug 2026 ยท projected 24 bars out
Oric Pharmaceuticals (ORIC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Aug 2026, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Nov 2026 | ๐Death | 4-hour | 14 bars out | Active Cross Test |
| 14 Aug 2026 | ๐จGolden steep | daily | 24 bars out | Not tested |
| 21 Jul 2026 | ๐จGolden | 4-hour | 28 bars out | Not tested |
| 8 May 2026 | ๐Death moderate | daily | 21 bars out | Not tested |
| 20 Apr 2026 | ๐Death | 4-hour | 22 bars out | 6 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.